PRESTINENZI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 513
EU - Europa 361
AS - Asia 291
AF - Africa 33
SA - Sud America 16
Totale 1.214
Nazione #
US - Stati Uniti d'America 509
SG - Singapore 100
CN - Cina 99
GB - Regno Unito 82
SE - Svezia 64
DE - Germania 56
IT - Italia 48
VN - Vietnam 33
RU - Federazione Russa 24
HK - Hong Kong 20
IE - Irlanda 20
IN - India 18
FR - Francia 15
TG - Togo 11
UA - Ucraina 11
BR - Brasile 10
NL - Olanda 10
ZA - Sudafrica 10
BG - Bulgaria 9
JO - Giordania 8
JP - Giappone 7
BE - Belgio 6
FI - Finlandia 5
NG - Nigeria 5
AR - Argentina 4
CA - Canada 4
EE - Estonia 4
SC - Seychelles 4
CH - Svizzera 3
CI - Costa d'Avorio 3
IR - Iran 3
PL - Polonia 2
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
CZ - Repubblica Ceca 1
LT - Lituania 1
PE - Perù 1
TW - Taiwan 1
UY - Uruguay 1
Totale 1.214
Città #
Southend 72
Ashburn 65
Singapore 64
Chandler 52
Fairfield 39
Ann Arbor 29
Wilmington 26
Princeton 24
Dong Ket 21
Seattle 21
Dublin 20
Hong Kong 20
Houston 19
Santa Clara 19
Cambridge 18
Woodbridge 16
Beijing 15
New York 15
Boardman 14
Nanjing 13
Lomé 11
Bologna 10
Bremen 9
Padova 9
Sofia 9
Turin 9
Westminster 9
Amman 8
Frankfurt am Main 8
Los Angeles 8
Jinan 7
Berlin 6
Brussels 6
Medford 6
Shenyang 6
Tokyo 6
Abeokuta 5
Dallas 5
Jacksonville 5
Mülheim 5
Changsha 4
Hebei 4
Helsinki 4
Ho Chi Minh City 4
Jiaxing 4
Kuban 4
Redwood City 4
Abidjan 3
Buffalo 3
Guangzhou 3
Hanoi 3
Munich 3
Redondo Beach 3
Saint Petersburg 3
San Diego 3
San Venanzo 3
São Paulo 3
Taiyuan 3
Tianjin 3
Zhengzhou 3
Bari 2
Bern 2
Dearborn 2
Olalla 2
Redmond 2
Roubaix 2
Shantou 2
Taizhou 2
Warsaw 2
Yubileyny 2
Zanjan 2
Adliswil 1
Arequipa 1
Belo Horizonte 1
Berazategui 1
Boa Nova 1
Boston 1
Buenos Aires 1
Bắc Ninh 1
Calgary 1
Changchun 1
Costa Mesa 1
Córdoba 1
Den Haag 1
Dongguan 1
Dubai 1
Düsseldorf 1
Florence 1
Goiânia 1
Haikou 1
Hangzhou 1
Hefei 1
Huaibei 1
Itaocara 1
Johannesburg 1
Joinville 1
Kunming 1
Lauterbourg 1
Milwaukee 1
Montevideo 1
Totale 847
Nome #
Cyclosporine lowering with everolimus versus mycophenolate mofetil in heart transplant recipients: Long-term follow-up of the SHIRAKISS randomized, prospective study. 154
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 150
Clinical and Prognostic Correlates of pAMR Grading in Patients with Suspect Antibody Mediated Rejection 149
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 142
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 135
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 132
PREDICTING CARDIOVASCULAR OUTCOMES LONG-TERM AFTER HEART TRANSPLANT BY LATE CHANGES IN MAXIMAL INTIMAL THICKNESS: BEYOND THE HYSTORICAL 1-YEAR LIMIT 132
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 132
Late Changes in Maximal Intimal Thickness after Heart Transplant: Prognostic Implications and Risk Factors 118
Totale 1.244
Categoria #
all - tutte 3.354
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.354


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202161 0 0 0 0 0 4 5 2 13 5 2 30
2021/2022169 11 5 4 19 18 6 2 10 7 25 31 31
2022/2023234 28 42 16 28 17 17 5 7 40 6 20 8
2023/202463 4 10 1 9 1 30 0 1 0 4 1 2
2024/2025188 12 39 30 13 24 7 13 4 0 14 7 25
2025/2026182 40 29 30 19 51 13 0 0 0 0 0 0
Totale 1.244